The PPI analysis of the 91 targets shows that the top 10 central targets, including AKT1, IL6, TNF, TP53, JUN, HIF1A, PTGS2, VEGFA, ESR1, and FOS, may be the key targets of the treatment of breast cancer. Here, PTGS2 is linked to breast carcinoma.